High-dimensional IHC-mass cytometry

Why is spatial information important when studying the tumor microenvironment?

Spatial imaging preserves the context of how cells are arranged in a tumour environment. Generating biological hypotheses and identifying potential biomarkers. explain treatment resistance

What does the TME consist of

• Tumor cells

• Fibroblasts

• Vasculature

• Myeloid immune cells, such as macrophages and neutrophils

• Lymphoid immune cells, such as T cells, B cells and NK cells

How do we study the spatial TME? 3 methods

Histochemistry

Uses chemical stains to reveal tissue structure and morphology. A classic example is H&E staining, which helps distinguish cells and tissue architecture but does not specifically identify many immune-cell subtypes.

Immunohistochemistry (IHC)

Uses antibodies to detect specific proteins in tissue. It preserves spatial information, but conventional assays generally examine a limited number of markers per section.

Immunofluorescence (IF)

Uses fluorescently labelled antibodies to detect proteins. Multiplex IF can measure several markers simultaneously, but overlapping fluorescence spectra limit how many markers can be distinguished reliably.

Why does spectral overlap limit multiplex immunofluorescence? How to solve this problem?

When two fluorescent signals overlap, the detector may have difficulty determining which fluorophore produced the measured light. This is called spectral overlap.

Imaging Mass Cytometry.

Three types of spatial analysis

1. Cell counts and tissue domains

How many cells are present, and are they located in the tumor or stroma?

This describes abundance and broad distribution.

2. Cell pairs and neighbours

Which cell types are close to one another? Are particular pairs of cells found together more often than expected?

This helps generate hypotheses about potential cell–cell interactions.

3. Multicellular communities or niches

Which recurring combinations of several cell types form local structures?

This can reveal coordinated cellular environments that may support immune activation or suppression.

Define a cellular community and explain why its composition and spatial organisation may influence immune function.

A cellular community spatially organised environment in which different cell types may interact functionally.

For example, a community containing DCs and T cells may support antigen presentation and T-cell activation. If Tregs are also abundant, the same environment may become suppressive.

How Tregs inhibit the T/DC community (a hot tumour has a t/dc community with tregs in it and the tumour isnt shrinking. explain why this could be)

1. Competition for co-stimulation

Tregs express CTLA-4, which binds CD80/CD86 on antigen-presenting cells with higher affinity than CD28. This limits the co-stimulatory signals available to conventional T cells.

2. Removal of co-stimulatory molecules

CTLA-4 can remove CD80/CD86 from antigen-presenting cells through trans-endocytosis, reducing their ability to provide co-stimulation.

3. Suppressive cytokines

Tregs secrete cytokines such as TGF-β, IL-10 and IL-35, which can inhibit effector immune-cell function.

Explain how a spatial pattern could be developed into a predictive biomarker.

• Define a reproducible spatial feature. For example, a specific T-cell/DC/Treg community or a quantitative measure of cellular proximity.

• Validate it independently. Test whether the same pattern can be measured reliably in independent patient cohorts.

• Establish clinical relevance. Determine whether it predicts treatment response or resistance, rather than merely correlating with tumor characteristics.

• Assess clinical utility. Demonstrate that using the biomarker to guide treatment improves clinical decision-making or patient outcomes.